Evidence map›Paper›PMID 23267442›Full record

ArticleFrontiers in cellular and infection microbiology2012

A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis.

David A Revelli, Julie A Boylan, Frank C Gherardini

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mutation ofMicrobiology spectrum · 2024
    Article
  6. Sequence specificity defines the effectiveness of PPMOs targetingAntimicrobial agents and chemotherapy · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Non-invasive administration of AAV to target lung parenchymal cells and develop SARS-CoV-2-susceptible mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. IL-1R and Inflammasomes Mediate Early Pulmonary Protective Mechanisms in RespiratoryFrontiers in cellular and infection microbiology · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Btp Proteins fromFrontiers in immunology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

David A RevelliLaboratory of Zoonotic Pathogens, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories Hamilton, MT, USA.
Julie A Boylan
Frank C Gherardini
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

The Roles of Key Transcription Factors on the Pathogenesis of B. Burgdorferi, the Causative Agent of Lyme DiseaseZIAAI000905 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GHERARDINI, FRANK · 2009 to 2023
$12.4M
Intramural NIH HHS
6 · The paper itself

Abstract

Pulmonary melioidosis, a disease manifestation caused by the bacterium Burkholderia pseudomallei, has been studied using aerosols or intranasal (IN) inoculation in small animal models. Both have inherent disadvantages which may not accurately model primary pulmonary melioidosis in humans. Intratracheal inoculation (IT) by direct visualization of the tracheal opening offers an alternative technique for infection that overcomes the disadvantages of aerosol and IN challenge. In this study, we describe a method which requires relatively inexpensive equipment, little training, and is compliant with the operational constraints of a BSL3 laboratory. Results obtained using trypan blue demonstrated that an inoculum can be accurately delivered into the lungs of mice within a biosafety cabinet (BSC). Whole body imaging and histopathology confirmed that mice inoculated intratracheally with B. pseudomallei develop the primary focus of infection in the lungs, and not the nasal passages which can lead to invasion of the central nervous system and potential neurologic complications. Further, based on colony counts and bioluminescent imaging, dissemination to secondary organs occurred as expected. Taken together, this intratracheal method of inoculation fulfills four goals: (1) to accurately deliver B. pseudomallei into the lungs of the animal model, (2) to avoid potentially confounding complications due to primary infections at sites other than the lung, (3) to maintain normal organ dissemination, and (4) to be BSL3 compliant.

Indexed as

Disease Models, AnimalInhalation ExposureAnimalsBurkholderia pseudomalleiFemaleHistocytochemistryLungMelioidosisMiceMice, Inbred BALB CPneumonia, BacterialWhole Body ImagingBurkholderia pseudomalleiintratracheal inoculationmelioidosisnon-invasive inoculation methodpulmonary melioidosis

Identifiers

PMID23267442
PMCPMC3526731
OpenAlexW2156564750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.